Scout Investments Inc. Decreases Stock Position in Integer Holdings Co. (NYSE:ITGR)

Scout Investments Inc. cut its holdings in Integer Holdings Co. (NYSE:ITGR) by 6.0% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 94,753 shares of the medical equipment provider’s stock after selling 5,996 shares during the period. Scout Investments Inc. owned about 0.28% of Integer worth $10,990,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Blue Trust Inc. lifted its holdings in Integer by 483.3% in the 4th quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 377 shares in the last quarter. Principal Securities Inc. acquired a new position in shares of Integer during the 4th quarter valued at about $67,000. Headlands Technologies LLC acquired a new position in shares of Integer during the 1st quarter valued at about $106,000. Quadrant Capital Group LLC increased its stake in shares of Integer by 10.2% during the 4th quarter. Quadrant Capital Group LLC now owns 1,427 shares of the medical equipment provider’s stock valued at $141,000 after acquiring an additional 132 shares during the last quarter. Finally, Strs Ohio increased its stake in shares of Integer by 54.5% during the 4th quarter. Strs Ohio now owns 1,700 shares of the medical equipment provider’s stock valued at $168,000 after acquiring an additional 600 shares during the last quarter. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Integer Stock Up 1.6 %

NYSE:ITGR traded up $1.92 during trading hours on Friday, hitting $125.22. The stock had a trading volume of 136,965 shares, compared to its average volume of 316,928. The company has a current ratio of 3.32, a quick ratio of 2.01 and a debt-to-equity ratio of 0.76. Integer Holdings Co. has a 1-year low of $69.40 and a 1-year high of $126.48. The business has a 50 day simple moving average of $118.18 and a two-hundred day simple moving average of $112.13. The company has a market cap of $4.19 billion, a PE ratio of 42.42, a price-to-earnings-growth ratio of 1.84 and a beta of 1.11.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.12 by $0.02. The company had revenue of $414.80 million during the quarter, compared to the consensus estimate of $412.78 million. Integer had a net margin of 6.01% and a return on equity of 11.25%. Integer’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter last year, the company earned $0.87 earnings per share. Analysts predict that Integer Holdings Co. will post 5.27 EPS for the current year.

Analyst Upgrades and Downgrades

ITGR has been the subject of a number of research analyst reports. Oppenheimer initiated coverage on shares of Integer in a research note on Tuesday. They set an “outperform” rating and a $135.00 price objective for the company. Citigroup upped their price objective on shares of Integer from $118.00 to $124.00 and gave the company a “neutral” rating in a research note on Wednesday, May 22nd. Benchmark reissued a “buy” rating and set a $130.00 target price on shares of Integer in a research report on Friday, May 10th. Truist Financial began coverage on shares of Integer in a research report on Wednesday, May 15th. They set a “buy” rating and a $137.00 target price for the company. Finally, Bank of America raised shares of Integer from a “neutral” rating to a “buy” rating and increased their target price for the stock from $105.00 to $135.00 in a research report on Monday, April 15th. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $128.88.

Insider Activity

In other news, Director James F. Hinrichs sold 9,603 shares of the stock in a transaction that occurred on Friday, May 24th. The stock was sold at an average price of $122.44, for a total transaction of $1,175,791.32. Following the completion of the transaction, the director now directly owns 7,424 shares in the company, valued at approximately $908,994.56. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In related news, VP Tommy P. Thomas sold 1,500 shares of the firm’s stock in a transaction on Tuesday, April 30th. The stock was sold at an average price of $114.00, for a total transaction of $171,000.00. Following the transaction, the vice president now directly owns 2,813 shares in the company, valued at $320,682. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director James F. Hinrichs sold 9,603 shares of the firm’s stock in a transaction on Friday, May 24th. The stock was sold at an average price of $122.44, for a total value of $1,175,791.32. Following the transaction, the director now owns 7,424 shares in the company, valued at $908,994.56. The disclosure for this sale can be found here. In the last three months, insiders sold 17,936 shares of company stock worth $2,130,937. 2.00% of the stock is currently owned by insiders.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.